Lomefloxacin, a new fluoroquinolone: Studies on in vitro antimicrobial spectrum, potency, and development of resistance
- 1 May 1989
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (3), 221-233
- https://doi.org/10.1016/0732-8893(89)90019-9
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Pharmacokinetics and tissue penetration of orally administered lomefloxacinAntimicrobial Agents and Chemotherapy, 1988
- Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral dosesAntimicrobial Agents and Chemotherapy, 1988
- Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testingDiagnostic Microbiology and Infectious Disease, 1988
- In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolonesAntimicrobial Agents and Chemotherapy, 1988
- In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agentsAntimicrobial Agents and Chemotherapy, 1988
- In vitro and in vivo activity of NY-198, a new difluorinated quinoloneAntimicrobial Agents and Chemotherapy, 1987
- The fluoroquinolones: pharmacology, clinical uses, and toxicities in humansAntimicrobial Agents and Chemotherapy, 1985